Background: The treatment of pemphigus is still challenging and some pemphigus patients are unresponsive to conventional immunosuppressive treatments. Rituximab, a chimeric monoclonal anti-CD20 antibody, binds to the CD20 antigen on the surfaces of B cells and has been reported to be effective for the treatment of recalcitrant pemphigus.
Objective: The aim of this study was to compare the efficacy of different doses of rituximab in patients with pemphigus who were unresponsive to conventional therapies.
Methods: Twenty-seven pemphigus patients who received different doses of rituximab (375mg/m2 per infusion weekly) were analyzed retrospectively. We ...
Clinical Efficacy of Different Doses of Rituximab in the Treatment of Pemphigus: A Retrospective Study of 27 patients is a post from: Skincare
Clinical Efficacy of Different Doses of Rituximab in the Treatment of Pemphigus: A Retrospective Study of 27 patients via BuzzBlazer.com
No comments:
Post a Comment